Previous Close | 12.38 |
1-Year Change | -57.98% |
6-Months Change | -46.34% |
3-Months Change | -55.32% |
Moving Avg (50d) | 25.105 |
Moving Avg (200d) | 26.478 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 1.39B |
Beta (3-Years) | 1.11 |
Revenue Growth (ttm) | 46.99% |
Net Profit Margin (ttm) | -5.08% |
Return On Assets (ttm) | -3.41% |
EPS (ttm) | -1.02 |
PE Ratio (ttm) | -12.14 |
Dividend Yield | % |
Asset Description: | Evolent Health, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Strong buy |
Forecast Date: | 2024-10-25 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
11.084 | 10.745 | 10.518 | 10.179 | 9.614 | 9.048 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.